ERDRP-0519

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
ERDRP-0519
File:ERDRP-0519.svg
Systematic (IUPAC) name
2-methyl-N-[4-[(2S)-2-(2-morpholin-4-ylethyl)piperidin-1-yl]sulfonylphenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide
Clinical data
Legal status
  • Investigational New Drug
Identifiers
CAS Number 1374006-96-8 YesY
PubChem CID: 57521469
Chemical data
Formula C23H30F3N5O4S
Molecular mass 529.574
  • C4COCCN4CCC1CCCCN1S(=O)(=O)c(cc3)ccc3NC(=O)c2cc(C(F)(F)F)nn2C

ERDRP-0519 is an antiviral drug which is the first drug specifically developed to target the measles morbillivirus. It acts as an inhibitor of the viral enzyme RNA polymerase which is essential for viral replication, and in animal studies showed good oral bioavailability and protected ferrets from otherwise lethal doses of a morbillivirus when administered up to three days after infection.[1][2]

See also

References

  1. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  2. ↑ Lua error in package.lua at line 80: module 'strict' not found.


<templatestyles src="Asbox/styles.css"></templatestyles>

Stub icon

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.
Retrieved from "https://infogalactic.com/w/index.php?title=ERDRP-0519&oldid=722740082"